Skip to content

Caphosol® Artifical Saliva 64 x 15 mL sachets aqueous solutionRecalls & reported problems

Eusa Pharma (Uk) Limited · Caphosol® is a preparation comprising two separately packaged aqueous solutions, a phosphate solution (Caphosol® A) and a calcium solution (Caphosol® B) which when both sachet solutions are combined in equal volumes form a solution supersaturated with respect to both calcium and phosphate ions. · Class U

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Jun 11, 2025Class IIOpen, Classified

    Out of specification stability test result for the Caphosol B solution from process validation lots

    Z-2012-2025 · Root cause: Device Design · Recall details · FDA record ↗

Other Saliva, Artificial devices

All Saliva, Artificial devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page